Montreal Cognitive Assessment (MoCA)

The prevalence of pollution, autism, ADHD, depression and cognitive slowing has garnered more attention in recent years. My experience in Springfield, MO opened my eyes to see the connection between contaminated water and a flood of ADHD patients with high cholesterol, low vitamin D, and a lot more thyroid disease than should have been expected. It turns out the PFAS epidemic has thousands of locations.

I decided to become certified in the Montreal Cognitive Assessment (MoCA) for two reasons. First, so that I could use the dementia screening test with veterans disability evaluations. Second, the research has continued to explode supporting it’s helpfulness in recent years. View the MoCA Clinic data and you’ll be impressed too. Their videos are worth the time if you really want to delve deeper in preventing and reversing dementia.

Book A Dementia Screening Test Today

You can be located anywhere in the world. You will need to take the results to your own physician for interpretation. This appointment type is not for diagnoses or medications.

It only takes 20 minutes and it could change your life.

References

  • Sebastian Corral, et al., Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis, Schizophrenia Research: Cognition, Volume 36, 2024, 100302, ISSN 2215-0013, https://doi.org/10.1016/j.scog.2024.100302.
  • Hsieh, M. L., Lu, Y. T., Lin, C. C., & Lee, C. P. (2021). Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial. BMC psychiatry21(1), 1-10.
  • Dautzenberg, G., Lijmer, J., & Beekman, A. (2020). Clinical value of the Montreal Cognitive Assessment (MoCA) in patients suspected of cognitive impairment in old age psychiatry. Using the MoCA for triaging to a memory clinic. Cognitive Neuropsychiatry, 1-17.
  • Hebbrecht, K., Giltay, E. J., Birkenhäger, T., Sabbe, B., Verwijk, E., Obbels, J., … & Van Diermen, L. Cognitive change after electroconvulsive therapy in mood disorders measured with the Montreal Cognitive Assessment. Acta psychiatrica Scandinavica.
  • Santangelo, G., D’Iorio, A., Peluso, S., Mautone, G., Vitale, C., Manganelli, F., … & Esposito, M. (2020). Personality traits associated with blepharospasm: A comparison with healthy subjects, patients with facial hemispasm and patients with hyperhidrosis. Journal of Clinical Neuroscience.
  • Gil-Berrozpe, G. J., Sánchez-Torres, A. M., de Jalón, E. G., Moreno-Izco, L., Fañanás, L., Peralta, V., … & Llano, K. (2019). Utility of the MoCA for cognitive impairment screening in long-term psychosis patients. Schizophrenia Research.
  • Murri, M. B., Respino, M., Proietti, L., Bugliani, M., Pereira, B., D’Amico, E., … & Girtler, N. (2019). Cognitive impairment in late life bipolar disorder: risk factors and clinical outcomes. Journal of affective disorders.
  • Gierus, J., Mosiołek, A., Koweszko, T., Wnukiewicz, P., Kozyra, O., & Szulc, A. (2015). The Montreal Cognitive Assessment as a Preliminary Assessment Tool in General Psychiatry: Validity of MoCA in psychiatric patients. General Hospital Psychiatry.